Polaryx Therapeutics, Inc. Shares (Basic) increased by 6.5% to $47.22M in Q1 2026 compared to the prior quarter.
A decreasing trend typically signals an aggressive share buyback program, which can increase the value of remaining shares.
Weighted-average shares outstanding (basic) is the calculation of the total number of common shares held by the public d...
Used to evaluate the scale of a company's equity base relative to its market capitalization and peer group.
weighted_shares_basic| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | 44.3M | 47.2M |
| QoQ Change | — | +6.5% |
| YoY Change | — | +6.5% |